Steegen K, Levin L, Evans D, Technau KG, Hans L. Minimal Cross-resistance to Tenofovir in Children and Adolescents Failing ART Makes Them Eligible for Tenofovir-Lamivudine-Dolutegravir Treatment. Pediatr Infect Dis J. 2022;41(10):827-34. https://journals.lww.com/pidj/Fulltext/2022/10000/Minimal_Cross_resistance_to_Tenofovir_in_Children.9.aspx